Kings Point Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Kings Point Capital Management's RMD Position: Q1 2022 in Review
Kings Point Capital Management held its ResMed (RMD) position steady in Q1 2022 at 206 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #346.
Kings Point Capital Management first reported a position in RMD in Q2 2014 and has held it in 32 quarters since. The position peaked at $100K in Q3 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.
- Kings Point Capital Management held 206 shares of ResMed worth $50K as of Q1 2022.
- Kings Point Capital Management left its ResMed share count unchanged in Q1 2022.
- ResMed made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #346 holding.
- Kings Point Capital Management first reported a position in ResMed in Q2 2014 and has held it in 32 quarters since.
- Kings Point Capital Management's ResMed position peaked at $100K in Q3 2021.
- 682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.
Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.